ProfileGDS4718 / 224486_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 59% 72% 62% 65% 73% 74% 58% 60% 64% 66% 62% 67% 72% 70% 67% 66% 64% 72% 67% 60% 67% 65% 65% 64% 71% 64% 73% 66% 77% 71% 75% 56% 62% 71% 78% 80% 62% 63% 78% 68% 69% 74% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4542665
GSM549102patient 115, normal, homogenized [OPG study]6.0894459
GSM549104patient 119, normal, homogenized [OPG study]7.1220372
GSM549108patient 138, normal, homogenized [OPG study]6.2909762
GSM549119patient 077, normal, homogenized [OPG study]6.4689565
GSM549133patient 032, cancer, homogenized [OPG study]7.2338273
GSM549139patient 042, cancer, homogenized [OPG study]7.2589974
GSM549099patient 107, normal, homogenized [OPG study]6.0144958
GSM549109patient 139, normal, homogenized [OPG study]6.1666360
GSM549110patient 046, normal, homogenized [OPG study]6.422264
GSM549114patient 063, normal, homogenized [OPG study]6.5351266
GSM549122patient 082, normal, homogenized [OPG study]6.3022762
GSM549134patient 033, cancer, homogenized [OPG study]6.5889167
GSM549136patient 036, cancer, homogenized [OPG study]7.1061272
GSM549140patient 044, cancer, homogenized [OPG study]6.8873770
GSM549111patient 047, normal, homogenized [OPG study]6.6678667
GSM549113patient 057, normal, homogenized [OPG study]6.577866
GSM549132patient 031, cancer, homogenized [OPG study]6.4137964
GSM549137patient 038, cancer, homogenized [OPG study]7.0472972
GSM549142patient 047, cancer, homogenized [OPG study]6.6408767
GSM549100patient 110, normal, homogenized [OPG study]6.1211460
GSM549107patient 135, normal, homogenized [OPG study]6.5841767
GSM549115patient 068, normal, homogenized [OPG study]6.4672465
GSM549116patient 072, normal, homogenized [OPG study]6.5191565
GSM549120patient 078, normal, homogenized [OPG study]6.3938864
GSM549131patient 030, cancer, homogenized [OPG study]7.0799371
GSM549118patient 074, normal, homogenized [OPG study]6.4200964
GSM549129patient 027, cancer, homogenized [OPG study]7.2302973
GSM549123patient 088, normal, homogenized [OPG study]6.5323466
GSM549124patient 006, cancer, homogenized [OPG study]7.5016977
GSM549126patient 015, cancer, homogenized [OPG study]6.9828871
GSM549128patient 025, cancer, homogenized [OPG study]7.3841875
GSM549103patient 117, normal, homogenized [OPG study]5.9238356
GSM549117patient 073, normal, homogenized [OPG study]6.1929562
GSM549138patient 041, cancer, homogenized [OPG study]7.0224171
GSM549141patient 045, cancer, homogenized [OPG study]7.7614578
GSM549130patient 028, cancer, homogenized [OPG study]7.8454480
GSM549101patient 111, normal, homogenized [OPG study]6.2728562
GSM549105patient 128, normal, homogenized [OPG study]6.3424363
GSM549106patient 134, normal, homogenized [OPG study]7.7801278
GSM549112patient 048, normal, homogenized [OPG study]6.6771568
GSM549125patient 011, cancer, homogenized [OPG study]6.7802769
GSM549127patient 024, cancer, homogenized [OPG study]7.3028474
GSM549135patient 035, cancer, homogenized [OPG study]7.8441879